Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants-Reference-Cited by-同舟云学术

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

Published:2008-05-14 Issue:7199 Volume:453 Page:1258-1261
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Collins Patrick J.,Haire Lesley F.,Lin Yi Pu,Liu Junfeng,Russell Rupert J.,Walker Philip A.,Skehel John J.,Martin Stephen R.,Hay Alan J.,Gamblin Steven J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature06956.pdf

Reference35 articles.

1. Kim, C. U. et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119, 681–690 (1997)

2. von Itzstein, M. et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418–423 (1993)

3. Varghese, J. N. et al. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6, 735–746 (1998)

4. McKimm-Breschkin, J. L. Resistance of influenza viruses to neuraminidase inhibitors–a review. Antiviral Res. 47, 1–17 (2000)

5. Gubareva, L. V., Webster, R. G. & Hayden, F. G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob. Agents Chemother. 45, 3403–3408 (2001)

Cited by 458 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Citrus-derived flavanones as neuraminidase inhibitors: In vitro and in silico study;European Journal of Medicinal Chemistry;2024-11

2. Sangbaipi decoction exerted in vitro and in vivo anti-influenza effect through inhibiting viral proteins;Journal of Ethnopharmacology;2024-09

3. Novel therapeutic agents for H5N1 influenza virus through 3D-QSAR, molecular docking, ADMET prediction, and DFT based global reactivity descriptors.;Journal of the Indian Chemical Society;2024-09

4. A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents;ACS Central Science;2024-07-04

5. CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase;2024-06-04